Asensus Surgical Inc (ASXC) Forecast, Price Target & Analyst Ratings

NYSEARCA:ASXC • US04367G1031

Current stock price

0.3479 USD
+0 (+0.64%)
At close:
0.3487 USD
+0 (+0.23%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Asensus Surgical Inc (ASXC).

Forecast Snapshot

Consensus Price Target

Price Target
$0.36
+ 2.62% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 12, 2024
Period
Q3 / 2024
EPS Estimate
-$0.06
Revenue Estimate
3.619M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
45.71%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$0.36
Upside
+ 2.62%
From current price of $0.35 to mean target of $0.36, Based on 7 analyst forecasts
Low
$0.35
Median
$0.36
High
$0.37

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for ASXC. The average price target is 0.36 USD. This implies a price increase of 2.62% is expected in the next year compared to the current price of 0.3479.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ASXC Current Analyst RatingASXC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

ASXC Historical Analyst RatingsASXC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
45.71%
ASXC was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about ASXC.
In the previous month the buy percentage consensus was at a similar level.
ASXC was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-05-16HC Wainwright & Co.Reiterate Neutral -> Neutral
2024-04-04HC Wainwright & Co.Downgrade Buy -> Neutral
2024-03-22HC Wainwright & Co.Maintains Buy -> Buy
2023-11-16Cantor FitzgeraldDowngrade Overweight -> Neutral
2023-11-15HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-22Cantor FitzgeraldReiterate Overweight -> Overweight
2023-08-11HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-12HC Wainwright & Co.Reiterate Buy -> Buy
2023-03-06HC Wainwright & Co.Maintains Buy
2023-02-22HC Wainwright & Co.Reiterate Buy
2023-01-10HC Wainwright & Co.Reiterate Buy
2022-09-08Cantor FitzgeraldInitiate Overweight
2022-08-10HC Wainwright & Co.Maintains Buy
2021-05-26HC Wainwright & Co.Initiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 12, 2024
Period
Q3 / 2024
EPS Estimate
-$0.06
Revenue Estimate
3.619M
Revenue Q2Q
232.32%
EPS Q2Q
19.86%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-3.90%
EPS (1 Month)
0.00%
EPS (3 Months)
-20.00%

Next Earnings Summary

ASXC is expected to report earnings on 11/12/2024. The consensus EPS estimate for the next earnings is -0.06 USD and the consensus revenue estimate is 3.62M USD.
The next earnings revenue estimate has been revised downward by 3.9% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
ASXC revenue by date.ASXC revenue by date.
8.23M
158.81%		7.09M
-13.85%		8.577M
20.97%		12.302M
43.43%		22.35M
81.68%		52.409M
134.49%		108.6M
107.22%		158.4M
45.86%		218.77M
38.11%		304.36M
39.12%
EBITDA
YoY % growth
ASXC ebitda by date.ASXC ebitda by date.
-50.51M
-10.19%		-63.17M
-25.06%		-75.365M
-19.31%		N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ASXC ebit by date.ASXC ebit by date.
-64.62M
-8.53%		-74.25M
-14.90%		-79.094M
-6.52%		-67.593M
14.54%		-56.414M
16.54%		-26.688M
52.69%		9.891M
137.06%		46.395M
369.06%		84.111M
81.29%		135.44M
61.03%
Operating Margin
ASXC operating margin by date.ASXC operating margin by date.
-785.18%-1,047.25%-922.16%-549.45%-252.41%-50.92%9.11%29.29%38.45%44.50%
EPS
YoY % growth
ASXC eps by date.ASXC eps by date.
-0.24
71.08%		-0.32
-33.33%		-0.31
3.13%		-0.24
21.03%		-0.19
20.83%		-0.08
57.89%		0.03
137.50%		0.12
300.00%		0.22
83.33%		0.36
59.09%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.06
19.86%		-0.04
32.00%		-0.03
61.75%		-0.03
66.00%		-0.03
45.45%		-0.03
25.00%
Revenue
Q2Q % growth		3.619M
232.32%		6.292M
15.85%		7.752M
590.29%		7.956M
260.49%		7.956M
119.84%		8.466M
34.55%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-15.452M
23.73%		-13.572M
13.13%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ASXC Yearly Revenue VS EstimatesASXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
ASXC Yearly EPS VS EstimatesASXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -2 -4 -6 -8 -10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
20.20%
EPS Next 5 Year
19.08%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
82.88%
Revenue Next 5 Year
79.22%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Asensus Surgical Inc / ASXC Forecast FAQ

Can you provide the average price target for Asensus Surgical Inc stock?

7 analysts have analysed ASXC and the average price target is 0.36 USD. This implies a price increase of 2.62% is expected in the next year compared to the current price of 0.3479.

What is the next earnings date for ASXC stock?

Asensus Surgical Inc (ASXC) will report earnings on 2024-11-12, after the market close.

What are the consensus estimates for Asensus Surgical Inc (ASXC) next earnings?

The consensus EPS estimate for the next earnings of Asensus Surgical Inc (ASXC) is -0.06 USD and the consensus revenue estimate is 3.62M USD.

Can you provide the expected long term growth rate for Asensus Surgical Inc stock?

The expected long term growth rate for Asensus Surgical Inc (ASXC) is 82.88%.